The DOI matches its Crossref record.
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.
Open accessAbstract
Recombinant monocyte chemotactic-activating factor (MCAF) has been shown to induce histamine release from human basophils with a dose response between 10(-9) and 10(-6) M. The peak of activity was reached at 10(-7) M. Histamine release by MCAF was rapid with an initial rate comparable with histamine release by an optimal dose of anti-IgE. MCAF led to peak histamine release within 1 min. 80% of the subjects tested were responsive to MCAF or anti-IgE, while all were responsive to FMLP. The percentage histamine release by MCAF was, however, less than that seen with anti-IgE or FMLP, but this was attributable to a lesser percent release in nonatopic subjects; atopic subjects responded similarly to all three agonists. MCAF was also shown to activate highly purified human basophils more readily than mixed leukocytes, and its activity was inhibited by a polyclonal rabbit antibody. At a suboptimal concentration (2.5 x 10(-9) M), MCAF was unable to prime the basophil to histamine release by other secretagogues. However, interleukin 3 (IL-3) and IL-5 could each prime basophils for MCAF-induced secretion. Therefore, our results suggest that MCAF may be a major contributor to the histamine-releasing activity seen in peripheral blood mononuclear cell supernatants that has been designated histamine releasing factor(s).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 859
Self-citationMolecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., & Schall, T. J. (1993) · Cell · doi:10.1016/0092-8674(93)90118-a · Cited by 763
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Kuziel, W. A., Morgan, S. J., Dawson, T. C., Griffin, S., Smithies, O., Ley, K., & Maeda, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12053 · Cited by 709
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
Chemokines, leukocyte trafficking, and inflammation
Schall, T. J., & Bacon, K. B. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90006-x · Cited by 615
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis
Gschwandtner, M., Derler, R., & Midwood, K. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02759 · Cited by 611
CC chemokines in allergic inflammation
Baggiolini, M., & Dahinden, C. A. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90156-2 · Cited by 529
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.
Goodman, R. B., Strieter, R. M., Martin, D. P., Steinberg, K. P., Milberg, J. A., Maunder, R. J., Kunkel, S. L., Walz, A., Hudson, L. D., & Martin, T. R. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810593 · Cited by 526
Schall, T. J., Bacon, K., Camp, R. D., Kaspari, J. W., & Goeddel, D. V. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1821 · Cited by 520
Forssmann, U., Uguccioni, M., Loetscher, P., Dahinden, C. A., Langen, H., Thelen, M., & Baggiolini, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2171 · Cited by 407
Interleukin-8 and the chemokine family
Baggiolini, M., Loetscher, P., & Moser, B. (1995) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)00088-6 · Cited by 400
Molecular Identification of an IgE-Dependent Histamine-Releasing Factor
MacDonald, S. M., Rafnar, T., Langdon, J., & Lichtenstein, L. M. (1995) · Science · doi:10.1126/science.7542803 · Cited by 365
Kaplan, A. P. (1979) · Cellular, Molecular, and Clinical Aspects of Allergic Disorders · doi:10.1007/978-1-4684-0988-8_8 · Cited by 363
Self-citationMonocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.
Taub, D. D., Proost, P., Murphy, W. J., Anver, M., Longo, D. L., van Damme, J., & Oppenheim, J. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117788 · Cited by 346
Self-citationMonocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.
Dahinden, C. A., Geiser, T., Brunner, T., von Tscharner, V, Caput, D., Ferrara, P., Minty, A., & Baggiolini, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.751 · Cited by 329
Neote, K., Mak, J., Kolakowski, L. J., & Schall, T. (1994) · Blood · doi:10.1182/blood.v84.1.44.44 · Cited by 278
Developments in laboratory diagnostics for isocyanate asthma
Wisnewski, A. V. (2007) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3280895d22 · Cited by 67
Seiffert, K., Ding, W., Wagner, J. A., & Granstein, R. D. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700135 · Cited by 62
Metadata
- Authors
- Kuna, P., Reddigari, S. R., Rucinski, D., Oppenheim, J. J., & Kaplan, A. P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1992-02-01
- Volume
- 175
- Issue
- 2
- Pages
- 489-493
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2124687307
- Cited by
- 178
- References
- 0
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.